Insider Buy/Sell Details for the Biotechnology Industry — Last 30 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1093)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
391
Price
$533.21
Total Value
$208.49K
Shares Held After
325,643
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
459
Price
$532.28
Total Value
$244.32K
Shares Held After
326,034
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
640
Price
$531.15
Total Value
$339.94K
Shares Held After
326,493
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,027
Price
$530.26
Total Value
$1.61M
Shares Held After
327,133
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,050
Price
$529.27
Total Value
$555.73K
Shares Held After
330,160
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
731
Price
$528.40
Total Value
$386.26K
Shares Held After
331,210
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
722
Price
$527.38
Total Value
$380.77K
Shares Held After
331,941
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$525.73
Total Value
$63.09K
Shares Held After
332,663
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
582
Price
$524.86
Total Value
$305.47K
Shares Held After
332,783
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
578
Price
$523.95
Total Value
$302.84K
Shares Held After
333,365
% of Holdings
0.2%
Lyell Immunopharma, Inc. (LYEL)
Lee Gary K. — Chief Scientific Officer
Shares
131
Price
$14.34
Total Value
$1.88K
Shares Held After
17,677
% of Holdings
0.7%
Lyell Immunopharma, Inc. (LYEL)
Hill Stephen J. — Chief Operating Officer
Shares
89
Price
$14.34
Total Value
$1.28K
Shares Held After
17,805
% of Holdings
0.5%
Entrada Therapeutics, Inc. (TRDA)
PARMAR KUSH — Director
Shares
92,444
Price
$7.00
Total Value
$647.11K
Shares Held After
2,691,337
% of Holdings
3.3%
CYTOKINETICS INC (CYTK)
Blum Robert I — Director
Shares
7,500
Price
$76.76
Total Value
$575.70K
Shares Held After
377,820
% of Holdings
1.9%
Ensysce Biosciences, Inc. (ENSC)
GOWER BOB G — Director
Shares
400,000
Price
$0.49
Total Value
$198.00K
Shares Held After
916,740
% of Holdings
43.6%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Veness Adam M — SVP, General Counsel and Sec.
Shares
616
Price
$111.18
Total Value
$68.49K
Shares Held After
0
% of Holdings
100.0%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Veness Adam M — SVP, General Counsel and Sec.
Shares
3,217
Price
$110.61
Total Value
$355.83K
Shares Held After
616
% of Holdings
83.9%
Immunome Inc. (IMNM)
Barchas Isaac — Director
Shares
15,248
Price
$26.06
Total Value
$397.36K
Shares Held After
72,416
% of Holdings
17.4%
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Moran Sean F. — Chief Financial Officer
Shares
12,000
Price
$10.08
Total Value
$120.97K
Shares Held After
84,694
% of Holdings
12.4%
Corbus Pharmaceuticals Holdings, Inc. (CRBP)
Cohen Yuval — Director
Shares
17,000
Price
$10.08
Total Value
$171.40K
Shares Held After
157,316
% of Holdings
9.8%
Spyre Therapeutics, Inc. (SYRE)
Albers Jeffrey W. — Director
Shares
10,000
Price
$104.68
Total Value
$1.05M
Shares Held After
9,360
% of Holdings
51.7%
Spyre Therapeutics, Inc. (SYRE)
Albers Jeffrey W. — Director
Shares
8,000
Price
$104.38
Total Value
$835.04K
Shares Held After
19,360
% of Holdings
29.2%
Spyre Therapeutics, Inc. (SYRE)
Albers Jeffrey W. — Director
Shares
5,000
Price
$104.47
Total Value
$522.35K
Shares Held After
0
% of Holdings
100.0%
MANNKIND CORP (MNKD)
Binder Steven B. — Director
Shares
39,051
Price
$4.06
Total Value
$158.55K
Shares Held After
785,867
% of Holdings
4.7%
Entrada Therapeutics, Inc. (TRDA)
5AM Ventures V, L.P. — 10% Owner
Shares
52,317
Price
$6.85
Total Value
$358.37K
Shares Held After
2,783,781
% of Holdings
1.8%
Entrada Therapeutics, Inc. (TRDA)
PARMAR KUSH — Director
Shares
52,317
Price
$6.85
Total Value
$358.37K
Shares Held After
2,783,781
% of Holdings
1.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$540.32
Total Value
$64.84K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
632
Price
$539.14
Total Value
$340.74K
Shares Held After
324,563
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
625
Price
$538.54
Total Value
$336.59K
Shares Held After
325,195
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
360
Price
$536.99
Total Value
$193.32K
Shares Held After
325,820
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$535.31
Total Value
$85.65K
Shares Held After
326,180
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$534.27
Total Value
$106.85K
Shares Held After
326,340
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
160
Price
$533.37
Total Value
$85.34K
Shares Held After
326,540
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
183
Price
$532.01
Total Value
$97.36K
Shares Held After
326,700
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,781
Price
$531.30
Total Value
$1.48M
Shares Held After
326,883
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,450
Price
$530.32
Total Value
$768.96K
Shares Held After
329,664
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
709
Price
$529.14
Total Value
$375.16K
Shares Held After
331,114
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
240
Price
$527.72
Total Value
$126.65K
Shares Held After
331,823
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
411
Price
$526.82
Total Value
$216.52K
Shares Held After
332,063
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,112
Price
$526.15
Total Value
$585.08K
Shares Held After
332,474
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
357
Price
$525.29
Total Value
$187.53K
Shares Held After
333,586
% of Holdings
0.1%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
3,500
Price
$8.62
Total Value
$30.17K
Shares Held After
83,500
% of Holdings
4.2%
PROTHENA CORP PUBLIC LTD CO (PRTA)
SCULLY WILLIAM P — 10% Owner
Shares
34,000
Price
$8.62
Total Value
$293.05K
Shares Held After
790,000
% of Holdings
4.3%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Garcia Marino — Director
Shares
21,909
Price
$108.72
Total Value
$2.38M
Shares Held After
65,292
% of Holdings
25.1%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Garcia Marino — Director
Shares
104,091
Price
$107.96
Total Value
$11.24M
Shares Held After
87,102
% of Holdings
54.4%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Garcia Marino — Director
Shares
800
Price
$110.76
Total Value
$88.61K
Shares Held After
191,292
% of Holdings
0.4%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Garcia Marino — Director
Shares
2,536
Price
$110.02
Total Value
$279.01K
Shares Held After
192,092
% of Holdings
1.3%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Garcia Marino — Director
Shares
2,373
Price
$109.10
Total Value
$258.89K
Shares Held After
194,628
% of Holdings
1.2%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Garcia Marino — Director
Shares
23,907
Price
$108.05
Total Value
$2.58M
Shares Held After
197,001
% of Holdings
10.8%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Garcia Marino — Director
Shares
10,384
Price
$107.49
Total Value
$1.12M
Shares Held After
220,908
% of Holdings
4.5%
Showing 701–750 of 1093 transactions (page 15 of 22)